Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$15.00 Web:$13.50 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters Display this book on your site! Related Titles A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap Review of NASA's Longitudinal Study of Astronaut Health Other Related Titles Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap: Interim Report (2005) Board on Health Sciences Policy (HSP) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 21   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix A Methods The committee developed this interim report and arrived at preliminary conclusions about the strengths and weaknesses of the BCPR during a five-month period from April 2004 to September 2004. During this time, the committee held three data-gathering sessions and met in closed session three times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix. The committee’s final report will provide a full list of meeting participants and contributors to the study process. Page 21 Front Matter (R1-R10) Interim Report (1-20) Appendix A Methods (21-25) Appendix B NASA. 2004. Bioastronautics Critical Path Roadmap (BCPR): An Approach to Risk Reduction and Management for Human Space Flight. Houston, TX: Lyndon B. Johnson Space Center (26-26) Appendix C Bibliography of Related National Academies Reports (27-27) Appendix D Committee and Staff Biographical Information (28-36)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 21
Preliminary Considerations Regarding NASA’s Bioastronautics Critical Path Roadmap: Interim Report Appendix A Methods The committee developed this interim report and arrived at preliminary conclusions about the strengths and weaknesses of the BCPR during a five-month period from April 2004 to September 2004. During this time, the committee held three data-gathering sessions and met in closed session three times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix. The committee’s final report will provide a full list of meeting participants and contributors to the study process.

OCR for page 22
Preliminary Considerations Regarding NASA’s Bioastronautics Critical Path Roadmap: Interim Report INSTITUTE OF MEDICINE AGENDA Committee on Aerospace Medicine and Medicine in Extreme Environments and Committee on Review of NASA’s Bioastronautics Critical Path Roadmap Keck Building 500 5th Street, NW Washington, DC Room 110 MONDAY, APRIL 12, 2004 CLOSED SESSION (committee and staff only) 8:00 a.m. – 12:00 p.m. OPEN SESSION 12:00 p.m. Lunch 1:15 p.m. Request for a review of the Bioastronautics Critical Path Roadmap Richard Williams, M.D., Chief Health and Medical Officer, NASA 2:00 p.m. Overview of the Bioastronautics Critical Path Roadmap NASA presenters: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Howard Ross, Acting Deputy Associate Administrator for Science, Office of Biological and Physical Research; Mark Shepanik, Aerospace Medicine Specialist, NASA; Frank Sulzman, Manager, Space Radiation Health Project 3:00 p.m. Break 3:30 p.m. Categories of critical research issues and metrics used in the Bioastronautics Critical Path Roadmap 4:10 p.m. Efficiency and technology issues in the Bioastronautics Critical Path Roadmap 4:50 p.m. Plenary discussion Led by David Longnecker, M.D. 5:30 p.m. Adjourn to reception and dinner with invited guests Location: third floor atrium

OCR for page 23
Preliminary Considerations Regarding NASA’s Bioastronautics Critical Path Roadmap: Interim Report INSTITUTE OF MEDICINE AGENDA Committee on Aerospace Medicine and Medicine in Extreme Environments and Committee on Review of NASA’s Bioastronautics Critical Path Roadmap Keck Building 500 5th Street, NW Washington, DC Room 110 TUESDAY, APRIL 13, 2004 OPEN SESSION 8:00 a.m. Continental breakfast 8:30 a.m. Welcoming remarks David Longnecker, M.D. 8:45 a.m. Overview of related work by the National Academies 9:00 a.m. Space Studies Board/Aeronautics and Space Engineering Board 9:30 a.m. Committee on Aerospace Medicine and Medicine in Extreme Environments 10:00 a.m. Break CLOSED SESSION (committee and staff only) 10:15 a.m. – 3:30 p.m.

OCR for page 24
Preliminary Considerations Regarding NASA’s Bioastronautics Critical Path Roadmap: Interim Report INSTITUTE OF MEDICINE AGENDA Committee on Review of NASA’s Bioastronautics Critical Path Roadmap Keck Building 500 5th Street, NW Washington, DC Room 204 WEDNESDAY, JUNE 9, 2004 OPEN SESSION 9:00 a.m. Welcome and overview of day’s agenda David Longnecker, M.D., and Lisa Vandemark, Ph.D. 9:15 a.m. Briefings related to the review of the Bioastronautics Critical Path Roadmap NASA presenters: Lauren Leveton, Bioastronautics Science Management Team, NASA; Holly Patton, Aerospace Technologist, NASA; David Tomko, Lead Scientist, Biomedical Program, NASA Bioastronautics Research Division; Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Frank Sulzman, Manager, Space Radiation Health Project 12:00 p.m. Lunch 1:00 p.m. Bone loss and countermeasures: historical perspectives and new in-flight clinical studies Jay Shapiro, M.D., Uniformed Services University 2:00 p.m Harmonization of crew living module and extravehicular pressure suit atmospheric constituents and pressures Bruce McCandless, M.S., M.B.A., Lockheed Martin 3:00 p.m. Break 3:30 p.m. An overview of space biology from cells to humans David Klaus, Ph.D., University of Colorado, Boulder 4:30 p.m. Plenary discussion Led by David Longnecker, M.D. 5:30 p.m. Adjourn THURSDAY, JUNE 10, 2004 CLOSED SESSION (committee and staff only) 8:30 a.m. – 3:00 p.m.

OCR for page 25
Preliminary Considerations Regarding NASA’s Bioastronautics Critical Path Roadmap: Interim Report INSTITUTE OF MEDICINE AGENDA Committee on Review of NASA’s Bioastronautics Critical Path Roadmap Keck Building 500 5th Street, NW Washington, DC Room 201 MONDAY, AUGUST 2, 2004 OPEN SESSION 9:00 a.m. Welcome, introductions, and overview of day’s agenda David Longnecker, M.D., and Lisa Vandemark, Ph.D. 9:20 a.m. Briefings related to the review of the Bioastronautics Critical Path Roadmap Richard Williams, M.D. 10:30 a.m. Break 11:00 a.m. Briefings related to the review of the Bioastronautics Critical Path Roadmap NASA presenters via videoconference from JSC: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Mark Shepanik, Aerospace Medicine Specialist, NASA; Desmond Lugg, Chief, Medicine of Extreme Environments, Office of the Chief Medical Officer 11:30 a.m. Question and answer discussion David Longnecker, M.D., moderator 12:00 p.m. Lunch 1:00 p.m. Advanced life support issues Brian Dunaway, Boeing Corporation CLOSED SESSION (committee and staff only) 2:30 p.m. – 5:30 p.m. TUESDAY, AUGUST 3, 2004 CLOSED SESSION (committee and staff only) 8:30 a.m. – 3:00 p.m.

Representative terms from entire chapter:

path roadmap